Cited by 793Immune cells in cancerImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells

Open access

Hoechst, Bastian, Ormandy, Lars A., Ballmaier, Matthias, Lehner, Frank, Krüger, Christine, Manns, Michael P., Greten, Tim F., Korangy, Firouzeh·2008·Gastroenterology

DOI 10.1053/j.gastro.2008.03.020

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Several studies have shown that development of hepatocellular carcinoma (HCC) generates a number of immune suppressive mechanisms in these patients. Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of cells that have been shown to inhibit T-cell responses in tumor-bearing mice, but little is known about these cells in humans owing to a lack of specific markers. In this study, we have investigated the frequency and function of a new population of MDSC denoted here as CD14(+)HLA-DR(-/low) in HCC patients. We have also identified a novel, MDSC-mediated immune regulatory pathway in these patients.Methods We have directly isolated and characterized MDSCs for phenotype and function from peripheral blood (n = 111) and tumor (n = 12) of patients with HCC.Results The frequency of CD14(+)HLA-DR(-/low) cells in peripheral blood mononuclear cells (PBMC) from HCC patients was significantly increased in comparison with healthy controls. CD14(+) HLA-DR(-/low) cells were unable to stimulate an allogeneic T-cell response, suppressed autologous T-cell proliferation, and had high arginase activity, a hallmark characteristic of MDSC. Most important, CD14(+)HLA-DR(-/low) cells from HCC patients induced a CD4(+)CD25(+)Foxp3(+) regulatory T-cell population when cocultured with autologous T cells.Conclusion CD14(+)HLA-DR(-/low) cells are a new population of MDSC increased in blood and tumor of HCC patients. We propose a new mechanism by which MDSC exert their immunosuppressive function, through the induction of CD4(+)CD25(+)Foxp3(+) regulatory T cells in cocultured CD4(+) T cells. Understanding the mechanism of action of MDSC in HCC patients is important in the design of effective immunotherapeutic protocols.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2008.03.020

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature reviews. Immunology · doi:10.1038/nri1806 · Cited by 2,135
Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1213 · Cited by 1,538
Immune surveillance of tumors
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,518
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Писарев, В. М., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J. P., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,176
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
Gao, Q., Qiu, S., Fan, J., Zhou, J., Wang, X., Xiao, Y., Xu, Y., Li, Y., & Tang, Z. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,134
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867

Show all 31 references

Sorted by citations

Items 601–700 of 790

Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models
Alghamri, M. S., Kamran, N., Kadiyala, P., Lowenstein, P. R., & Castro, M. G. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.05.047 · Cited by 9
Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow–bone marrow transplantation plus fetal thymus transplantation
Hosaka, N., Cui, W., Zhang, Y., Takaki, T., Inaba, M., & Ikehara, S. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0840-2 · Cited by 9
Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies
Wirth, T. C. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.862497 · Cited by 9
CXCL10 and CCL2 mRNA expression in monocytes is inversely correlated with the HLA-DR lower fraction of monocytes in patients with renal cell carcinoma
Motoshima, T., Komohara, Y., Horlad, H., Tsukamoto, H., Fujita, M., Saito, Y., Tanoue, K., Kasejima, Y., Sugiyama, Y., Kawano, Y., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.4132 · Cited by 9
CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC
Greten, T. F., & Korangy, F. (2017) · Gut · doi:10.1136/gutjnl-2017-315091 · Cited by 9
Self-citation
Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus
Bonilla, C. M., McGrath, N., Fu, J., & Xie, C. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.58 · Cited by 9
Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis
Rapposelli, I. G., Matteis, S. D., Lanuti, P., Valgiusti, M., Bartolini, G., Ulivi, P., Marisi, G., Pedica, F., Burgio, V., Frassineti, G. L., et al. (2021) · Cancers · doi:10.3390/cancers13020213 · Cited by 9
Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma
He, Q., Guo, P., Bo, Z., Yu, H., Yang, J., Wang, Y., & Chen, G. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02643-6 · Cited by 8
The Roles of Myeloid-Derived Suppressor Cells in Liver Disease
Zhang, C., Sui, Y., Liu, S., & Yang, M. J. (2024) · Biomedicines · doi:10.3390/biomedicines12020299 · Cited by 8
Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression
Brennecke, P., Allavena, P., Laface, I., Mantovani, A., & Bottazzi, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_2 · Cited by 8
Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies
Olivares-Hernández, A., Figuero-Pérez, L., Terán‐Brage, E., López-Gutiérrez, Á., Tamayo-Velasco, Á., González‐Sarmiento, R., Cruz, J. J., & Miramontes‐González, J. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091919 · Cited by 8
Fluorescent Detection of Peroxynitrite Produced by Myeloid-Derived Suppressor Cells in Cancer and Inhibition by Dasatinib
Carlson, E. J., Savardekar, H., Hu, X., Lapurga, G., Johnson, C. W., Sun, S. H., Carson, W. E., & Peterson, B. R. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00014 · Cited by 8
The role of dendritic cell subsets in 2,4,6-trinitrobenzene sulfonic acid-induced ileitis
Hoshino, S., Inaba, M., Iwai, H., Ito, T., Li, M., Gershwin, M. E., Okazaki, K., & Ikehara, S. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.10.002 · Cited by 8
An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation
Khan, A. H., Nasr, P., El‐Charabaty, E., & El‐Sayegh, S. (2016) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2411w · Cited by 8
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer
Aderonke, A. B., Ibrahim, R. B., & Huang, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184624 · Cited by 8
IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS
Salem, M. L., Zidan, A. A., Attia, M., El-Naggar, R., Nassef, M., Azm, A. R. A. E., El-Bate, H., Yussif, M., Galal, S., Senna, M. A., et al. (2017) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2017.1320670 · Cited by 8
Inhibition of Inflammatory Cytokines and Induction of Myeloid‐Derived Suppressor Cells by the Effects of Granulocyte and Monocyte Adsorption Apheresis
Sakanoue, M., Higashi, Y., & Kanekura, T. (2017) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12580 · Cited by 8
Accumulation of High Levels of Monocytic Myeloid-Derived Suppressor Cells Enhances Graft Survival in Almost-Tolerant Kidney Transplant Recipients
Du, X., Guo, Y. L., Zhao, Y., Yang, M. J., Chang, S., Liu, B., Cai, L., & Chen, Z. K. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2018.04.043 · Cited by 8
Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis
Zhang, Q., Yu, T., Tan, H., & Shi, H. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03245-4 · Cited by 7
Radio-immunomics in hepatocellular carcinoma: Unraveling the tumor immune microenvironment
Liu, Q., Zhu, W., Song, F., Lou, T., He, L., Zhou, W., & Feng, Z. (2024) · Meta-Radiology · doi:10.1016/j.metrad.2024.100098 · Cited by 7
Inflammatory Models Drastically Alter Tumor Growth and the Immune Microenvironment in Hepatocellular Carcinoma
Markowitz, G. J., Michelotti, G. A., Diehl, A. M., & Wang, X.-F. (2015) · 中国科学通报：英文版 · doi:10.1007/s11434-015-0772-5 · Cited by 7
The proportion and function of peripheral myeloid-derived suppressor cells do not correlate with systemic inflammation in chronic obstructive pulmonary disease
Tan, D. B. A., Fernández, S., Price, P., & Moodley, Y. P. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.09.011 · Cited by 7
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma
Yu, S. J., & Greten, T. F. (2020) · Journal of Liver Cancer · doi:10.17998/jlc.20.1.1 · Cited by 7
Self-citation
215 A PHASE II OPEN LABEL TRIAL EVALUATING SAFETY AND EFFICACY OF A TELOMERASE PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
Greten, T. F., Forner, A., Korangy, F., Nkontchou, G., Barget, N., Ayuso, C., Ormandy, L. A., Manns, M. P., Beaugrand, M., & Bruix, J. (2010) · Journal of Hepatology · doi:10.1016/s0168-8278(10)60217-6 · Cited by 7
Self-citation
Natural suppressor cells; past, present and future
Forghani, P. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/454 · Cited by 7
Pancreatic Cancer Fostered Immunosuppression Privileges Tumor Growth and Progression
Basso, D. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000278 · Cited by 7
Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to Mycobacterium tuberculosis
Namdev, P., Patel, S., Sparling, B. A. T. E., & Garg, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.647019 · Cited by 7
Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer
Goedegebuure, P. S. (2011) · Current Cancer Drug Targets · doi:10.2174/1568211215996340096 · Cited by 7
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers
Ma, C., Awosika, J. A., B., M. C. M., Coffman, K., Xie, C., Skorupan, N., Hrones, D. M., Liu, M., Ma, L., Wood, B. J., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217975 · Cited by 6
Self-citation
Multi-omics profiling of intercellular immunometabolic heterogeneity highlights in lung cancer: Crosstalk mechanisms and resistance in the tumor–immune interface
Rukonge, P. A., Kawuribi, V., Sheng, Y., Wei, Q., Kun, Y., Niyodukunda, P., Wang, T., Lu, Z., Miao, Y., Xu, K., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105094 · Cited by 6
Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approach
Newell, P., Cottam, B., Savage, T., Hammill, C. W., Wolf, R., Bifulco, C. B., Xiao, H., Crocenzi, T. S., Hansen, P., Crittenden, M. R., et al. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.02.002 · Cited by 6
Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19
Nam, H., Koh, J., Jung, J. H., Jeong, H., Jeong, H. W., Cheon, S., Park, S., Ys, K., & Shin, E. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200290 · Cited by 6
Fallen Angels or Risen Apes? A Tale of the Intricate Complexities of Imbalanced Immune Responses in the Pathogenesis and Progression of Immune-Mediated and Viral Cancers
Ondondo, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00090 · Cited by 6
Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis
Zhang, J., Zhang, Y., Yang, Z., Cheng, D., Zhang, H., Wei, L., Liu, C., Yan, F., Li, C., Dong, G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1091541 · Cited by 6
Peritoneal Immunity in Liver Disease
Delo, J., Forton, D. M., Triantafyllou, E., & Singanayagam, A. (2023) · Livers · doi:10.3390/livers3020016 · Cited by 5
Dual regulatory role of natural killer T cells during development of hepatocellular carcinoma
Papanastasatou, M., Gioulbasani, M., Nakou, E., Galaras, A., Rubio-Tomás, T., Talianidis, I., Eliopoulos, A., Hatzis, P., & Verykokakis, M. (2025) · Communications Biology · doi:10.1038/s42003-025-08872-5 · Cited by 5
Decreased DIO3OS Expression Predicts Poor Prognosis in Hepatocellular Carcinoma and is Associated with Immune Infiltration
Wang, Y., Sun, P., Hao, X., Cao, D., Liu, J., & Zhang, D. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10345-5 · Cited by 5
Immunomodulatory role of vitamin D and emerging immunotherapies in hepatocellular carcinoma
Chiriva‐Internati, M., Grizzi, F., Monari, M., Taverna, G., Figueroa, J. A., Daoyan, W., & Bresalier, R. S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1611829 · Cited by 6
Synergizing liver systemic treatments with interventional oncology: friend or foe?
Jost, R., Alshatti, N., Ghosn, M., Bonnet, B., Champiat, S., Deschamps, F., Gelli, M., Boige, V., Danlos, F., Susini, S., et al. (2022) · British Journal of Radiology · doi:10.1259/bjr.20220548 · Cited by 5
The mononuclear phagocyte system in hepatocellular carcinoma
Qiao, D.-R., Shan, G.-Y., Wang, S., Cheng, J.-Y., Yan, W., & Li, H.-J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i45.6345 · Cited by 5
Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
Zhang, Y., Zhan, L., Li, J., Jiang, X., & Li, Y. (2023) · Aging · doi:10.18632/aging.204679 · Cited by 5
Cancer immunotherapy: Targeting immunosuppressive tumor microenvironment
Ahmed, N., Adil, A. M., LAVANYA, V. A., & Jamal, S. (2014) · Oncobiology and Targets · doi:10.4103/2395-4469.145382 · Cited by 5
The cell composition of infused donor lymphocyte has different impact in different types of allogeneic hematopoietic stem cell transplantation
Zhao, X., Wang, Y., Yan, C., Wang, J., Zhang, X., Xu, L., Liu, K., & Huang, X. (2014) · Clinical Transplantation · doi:10.1111/ctr.12404 · Cited by 5
Tumor-induced Myeloid-derived Suppressor Cells
Ostrand‐Rosenberg, S., Sinha, P., Beury, D. W., Chornoguz, O., & Parker, K. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00028-2 · Cited by 5
Immunotherapy for hepatocellular carcinoma: the force awakens in HCC?
Feun, L. G., Li, Y., Wangpaichitr, M., Wu, C., & Savaraj, N. (2017) · Hepatoma Research · doi:10.20517/2394-5079.2016.45 · Cited by 5
Changes in the frequency of myeloid-derived suppressor cells after transarterial chemoembolization with gelatin sponge microparticles for hepatocellular carcinoma
Yue, Y., Ren, Z., Liu, Y., & Zhang, Y. (2019) · Journal of interventional medicine · doi:10.1016/j.jimed.2019.05.006 · Cited by 5
Tumor-derived MDSCs inhibit airway remodeling in asthmatic mice through regulating IL-10 and IL-12.
Zhang, Y., Xu, B., Luan, B., Zhang, Y., Wang, X., Xiong, X., & Shi, H. (2019) · PubMed · Cited by 5
Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells
Chen, D., Cheng, J., Zhong, Y., Liu, R., Lu, Z., & Luo, X. (2022) · Oncogene · doi:10.1038/s41388-022-02298-7 · Cited by 5
Clinical significance of FBXO43 in hepatocellular carcinoma and its impact on tumor cell proliferation, migration and invasion
Ma, R., Liu, W., Sun, T., Dang, C., & Li, K. (2023) · PeerJ · doi:10.7717/peerj.15373 · Cited by 5
Immunotherapy and radiation therapy for gastrointestinal malignancies: hope or hype?
Badiyan, S. N., Kaiser, A., Eastman, B., Forsthoefel, M. K., Zeng, J., Unger, K. R., & Chuong, M. D. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.10.07 · Cited by 5
Myeloid-Derived Suppressor Cells in Cancer
Kyriakopoulos, C. E., Montero, A. J., & Diaz-Montero, C. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8809-5_1 · Cited by 5
Myeloid-Derived Suppressor Cells in Cancer
Serafini, P., & Bronte, V. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3_8 · Cited by 5
Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients
Wang, P., Li, C., Ma, X., & Gai, X. (2020) · Medicine · doi:10.1097/md.0000000000020044 · Cited by 5
Trained immunity in pregnancy: Impact on maternal-fetal outcomes and mechanistic insights
Liu, S., Liang, J., Yang, D., Yang, L., Cai, S., Wang, L., Yin, T., & Diao, L. (2025) · Placenta · doi:10.1016/j.placenta.2025.09.015 · Cited by 4
Immunotherapy in hepatocellular cancer
Fountzilas, C. K., Evans, R., Alaklabi, S., & Iyer, R. V. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2020.12.002 · Cited by 4
Could the Crosstalk Between Myeloid-Derived-Suppressor Cells and Regulatory T Cells Have a Role in Beta-Thalassemia?
Zahran, A. M., El‐Badawy, O., Badawy, E. R., Elsayh, K. I., Gad, E. F., Saad, K., Mahmoud, K. H., Elhoufey, A. A., Dailah, H. G., & Ghazaly, M. (2023) · Journal of Hematology · doi:10.14740/jh1149 · Cited by 4
Engineering immune response to regulate cardiovascular disease and cancer
Rani, D., Kaur, S., Shahjahan, Dey, J. K., & Dey, S. K. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.12.004 · Cited by 4
Immune suppression and evasion in patients with head and neck cancer
Sakakura, K., & Chikamatsu, K. (2013) · Advances in Cellular and Molecular Otolaryngology · doi:10.3402/acmo.v1i0.21809 · Cited by 6
The Role of Monocytes/Macrophages in HBV and HCV Infection
Li, H., & Tu, Z. (2017) · InTech eBooks · doi:10.5772/intechopen.68353 · Cited by 4
Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives
Boyer, T., Blaye, C., Larmonier, N., & Domblides, C. (2022) · Cells · doi:10.3390/cells11030554 · Cited by 8
Immune Suppressive Myeloid-Derived Suppressor Cells in Cancer
Ostrand‐Rosenberg, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.17015-8 · Cited by 4
Immune-related adverse events in patients with low baseline serum IL-6 treated with durvalumab plus tremelimumab for hepatocellular carcinoma: a case series
Nobusawa, T., Kaneko, S., Murakawa, M., Tsuchiya, J., Miyoshi, M., Kawai‐Kitahata, F., Nakagawa, M., Kakinuma, S., Asahina, Y., & Okamoto, R. (2025) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-025-02176-1 · Cited by 3
Reprogramming ferroptosis in MDSCs: For state-dependent immunotherapy combinations
Li, Y., & Zhao, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189571 · Cited by 3
Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment
Rennert, C., Lang‐Meli, J., Gromak, M., Hofmann, M., Thimme, R., & Roehlen, N. (2022) · Liver Cancer International · doi:10.1002/lci2.70 · Cited by 3
Liver fibrosis
Chen, W., Yang, A., Zhang, N., & You, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00014-0 · Cited by 3
The immune response in paediatric cancer
Morgenstern, D. A., & Anderson, J. (2010) · Cited by 3
An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
Li, G., Xu, S., Yang, S., Wu, C., Zhang, L., & Wang, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1029576 · Cited by 3
Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor
Missale, G., & Cariani, E. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.72 · Cited by 3
A novel methodology of the myeloid-derived suppressor cells (MDSCs) generation with splenic stroma feeder cells
Tian, F., Jiang, P., Wu, M. H., Xing, Y., Liu, L., Dai, X., Tang, H., Yang, Z., Wang, L., & Zhu, X. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112119 · Cited by 3
Immune Therapies
Brown, Z. J., & Greten, T. F. (2019) · Molecular and translational medicine · doi:10.1007/978-3-030-21540-8_12 · Cited by 3
Self-citation
Tumor immunology
Sharif, P. M., Khoshbin, A. P., Nasrollahzadeh, E., Keshavarz‐Fathi, M., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00003-7 · Cited by 3
Growth of HepG2 Cells was Suppressed Through Modulation of STAT6/IL-4 and IL-10 in RAW 264.7 Cells Treated by Phytoglycoprotein (38 kDa)
Lee, J. Y., & Lim, K. (2012) · Inflammation · doi:10.1007/s10753-012-9576-9 · Cited by 3
What Are the Immune Obstacles to Liver Xenotransplantation Which Is Promising for Patients with Hepatocellular Carcinoma?
Yılmaz, S., Şahin, T. T., & Sağlam, K. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00495-9 · Cited by 3
Guardian and Selective Killer: The Versatile Functions of TLR3 in Hepatocellular Carcinoma
Liu, C. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs475 · Cited by 3
A preliminary study of IgG4 expression and its prognostic significance in oral squamous cell carcinoma
Fukuda, H., Uehara, T., Nakajima, T., Iwaya, M., Asaka, S., & Kurita, H. (2024) · BMC Cancer · doi:10.1186/s12885-024-12048-5 · Cited by 2
Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate
Angell, C. D., Lapurga, G., Sun, S. H., Johnson, C. W., Savardekar, H., Rampersaud, I. V., Fletcher, C., Albertson, D., Ren, C., Suarez‐Kelly, L. P., et al. (2024) · Nanomaterials · doi:10.3390/nano14181509 · Cited by 2
Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma
Mo, Y., Zou, Z., & Chen, E. (2024) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0117 · Cited by 2
Unraveling the obesity paradox in hepatocellular carcinoma: relative role of elevated body mass index on detrimental effects of postoperative complications
Akabane, M., Kawashima, J., Altaf, A., Woldesenbet, S., Cauchy, F., Aucejo, F., Popescu, I., Kitago, M., Martel, G., Ratti, F., et al. (2025) · HPB · doi:10.1016/j.hpb.2025.05.005 · Cited by 2
Hepatocellular Carcinoma – from Immunobiology to Immunotherapy
Roehlen, N., Bengsch, B., Rennert, C., Schultheiß, M., & Thimme, R. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2722-5684 · Cited by 2
New perspectives in immunotherapy for hepatocellular carcinoma: Focusing on resistance mechanism, biomarker, and personalized treatment
Wang, N., Liu, L., Xu, B., Wang, F., Sun, L., & Ye, Q. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105305 · Cited by 2
Immune Therapy
Lievense, L. A., Aerts, J. G. J. V., & Hegmans, J. P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24223-1_4 · Cited by 2
Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy
Wang, Y., Yan, C., Su, C., Wang, Y., Luo, S., Lü, J., Zhao, C., Zhao, G., & Xi, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.902384 · Cited by 2
Reversing the NK inhibitory tumor microenvironment by targeting suppressive immune effectors
Navin, I., & Parihar, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822620-9.00011-2 · Cited by 2
Xuanhusuo powder has an anti-breast cancer effect by inhibiting myeloid-derived suppressor cell differentiation in the spleen of mice through down-regulating granulocyte colony stimulating factor
Mao, Y., Liu, X., He, K., Chen, L., He, B., & Gao, J. (2023) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2022-0353 · Cited by 2
Regulatory T-Cells and Th17 Cells in Tumor Microenvironment
Kim, C. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_6 · Cited by 2
High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection
Grützner, E. M., Neizert, A., Stirner, R., Conca, R., Andrä, I., Wolff, L. S., Schiemann, M., Holdt, L. M., Klein, C., Bogner, J. R., et al. (2020) · Translational Medicine Communications · doi:10.1186/s41231-019-0052-5 · Cited by 2
Myeloid-Derived Suppressor Cells and Tumor Growth
Raffaghello, L., & Bianchi, G. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_5 · Cited by 2
Decreased accumulation of immune regulatory cells is correlated to the antitumor effect of IFN-γ overexpression in the tumor
pez, D. L. ⁄. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1169 · Cited by 2
Immunotherapy for Renal Cell Carcinoma
Davar, D., Fenton, M. J., & Appleman, L. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-062-5_16 · Cited by 2
Broad-Spectrum Immunosuppression by Classless Monocytes in Non-Hodgkin‘s Lymphoma
Vari, F., & Gandhi, M. K. (2011) · Immunotherapy · doi:10.2217/imt.11.56 · Cited by 2
Anti-VEGFR Therapy as a Partner for Immune-Based Therapy Approaches in HCC
Shigeta, K., Hato, T., Chen, Y., & Duda, D. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-64958-0_6 · Cited by 2
SERUM SOLUBLE CD25 IN HEPATOCELLULAR CARCINOMA, SHALL WE BE ABLE TO CHANGE THE NATURAL HISTORY?
Sameea, E. A., Zakareya, T., Metwaly, K., Youssef, A. A., Kamal, H. M., & Abdalla, W. M. (2017) · International Journal of Medicine and Medical Research · doi:10.11603/ijmmr.2413-6077.2017.2.8009 · Cited by 2
Characterization of monocytic and granulocytic subsets of myeloid‐derived suppressor cells in blood donors with occult hepatitis B virus infection
Zhang, W., Huang, J., Wang, M., Song, D., Liao, Q., Xia, R., Li, T., Allain, J., Ren, G., Fu, Y., et al. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25242 · Cited by 2
Prognostic Factors Contributing to the Survival of Hematopoietic Stem Cell Transplantation in the General Population with Leukemia: a Systematic Review
Tayuwijaya, K., Raharja, S. L., Rosana, M., & Nurhayati, R. W. (2022) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-022-00269-8 · Cited by 2
Myeloid-Derived Suppressor Cells in Tumor-Induced T Cell Suppression and Tolerance
Serafini, P., & Bronte, V. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_4 · Cited by 2
Tumor-Associated Macrophages
Sica, A., Straus, L., & Allavena, P. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_20 · Cited by 3
Role of Myeloid-Derived Suppressor Cells and Regulatory T-Cells in the Tuberculous Granuloma
Cheung, L. S., Srikrishna, G., & Bishai, W. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-25381-3_4 · Cited by 2
Receptor-interacting protein in malignant digestive neoplasms
Zhang, L., Guo, W., Yu, J., Li, C., Li, M., Chai, D., Wang, W., & Deng, W. (2021) · Journal of Cancer · doi:10.7150/jca.57076 · Cited by 3
Biological Therapy of Cancer
Avendaño, C., & Menéndez, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-62649-3.00012-0 · Cited by 2
Lipid peroxidation and superoxide dismutase activity in pea seedlings under clinorotation.
Бараненко, В. В. (1998) · PubMed · Cited by 2

Authors: Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F.
Affiliations: Medizinische Hochschule Hannover (DE)
Corresponding author: Korangy, Firouzeh
ORCID: Ballmaier, Matthias
Lehner, Frank
Manns, Michael P.
Greten, Tim F.
Korangy, Firouzeh
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2008-07
Volume: 135
Issue: 1
Pages: 234-243
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2008.03.020
OpenAlex: W2059688175
Cited by: 793
References: 31
Citations by year: 2026: 18 · 2025: 20 · 2024: 25 · 2023: 34 · 2022: 50 · 2021: 46 · 2020: 53 · 2019: 40 · 2018: 39 · 2017: 60 · 2016: 54 · 2015: 65 · 2014: 55 · 2013: 65 · 2012: 59
FWCI: 15.02
Type: journal article
Language: en
Update notices: erratum (2011-08-01)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft (SFB-738)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: myeloid-derived suppressor cells, hepatocellular carcinoma, regulatory T cells, immunosuppression, arginase activity, CD4+CD25+Foxp3+ T cells, tumor immune microenvironment, T cell proliferation inhibition, cancer immunotherapy
MeSH terms: Aged, Arginase, Cell Communication, Cell Division, Cells, Cultured, Female, Flow Cytometry, Carcinoma, Hepatocellular, HLA-DR Antigens, Humans, Immune Tolerance, Liver Neoplasms, Male, Middle Aged, Biomarkers, CD4-Positive T-Lymphocytes, CD4 Antigens, Immunophenotyping, Interleukin-10, Lipopolysaccharide Receptors, Myeloid Cells, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks